Skip to main content

Table 1 The administration and effect of histone PTMs regulators on DKD

From: Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective

Inhibitors category

Experimental models

Administration stage

Duration of treatment

Mechanisms

Ref

HAT inhibitor

     

Curcumin

STZ-induced SD rats

DM

4 weeks

alleviate the increase expression of ECM proteins by inhibiting HAT p300 and its binding factor NF-κB

[83]

C66

STZ-induced mice

DM

12 weeks

inhibit the increase in H3K9/14ac levels and p300/CBP occupancy on gene promoters of TCGF, PAI-1, and FN-1

[84]

HDAC inhibitor

     

TSA

STZ-induced SD rats

DM

4 weeks

Suppresses TGF-β1-induced epithelial-to-mesenchymal transition and activation of HDAC2

[85, 86]

Valproic acid

STZ-induced SD rats

DM

8 weeks

exert anti-inflammatory activity via reducing NF-κB and improve kidney function by reducing renal damage and fibrosis

[87]

Drugs

     

TSG

STZ-induced SD rats

DM

8 weeks

inhibit oxidative stress, inflammatory, and

expression of TGF-β1 partly mediated by activation of SIRT1

[88]

Esculetin

STZ-induced SD rats

DKD

8 weeks

attenuate alteration in Mmp13 and Bmp6 gene expression by involving change in

acetylation and methylation of histone H3

[89]